Learn more about utilizing pharmacogenetic (PGx) testing before prescribing medications to patients. PGx testing has the potential to improve outcomes for patients in multiple areas of medicine. Current guidelines for pharmacogenetic prescribing of opioids, antidepressants, and statins have been updated based on review of recent data. Participants will work through cases involving ordering and using PGx testing to inform prescribing choices for opioids, antidepressants, and statins.

Learning Objectives

At the conclusion of this activity, participants should be able to:

• Explain how genetics plays a role in drug metabolism/response
• Order appropriate pharmacogenetic testing for a specific patient case
• Utilize pharmacogenetic prescribing recommendations to optimize choice of opioid medications with clinical correlations to genomic variations
• Utilize pharmacogenetic prescribing recommendations to optimize choice of antidepressant medications with clinical correlations to genomic variations
• Utilize pharmacogenetic prescribing recommendations to optimize choice of statin medications with clinical correlations to genomic variations